Himalaya Nutravedics IPO
Market Sentiment
IPO Details
Day-wise Subscription (times subscribed)
Market Lot Size
IPO Reservation
Financial Analysis
Financial Data
Financial Performance
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 14.43 | 21.00 | 43.12 |
| Expense | 13.83 | 18.75 | 35.64 |
| Profit (PAT) | 0.43 | 2.23 | 7.39 |
| Total Assets | 6.09 | 10.82 | 24.42 |
Peer Comparison
| Company | EPS | P/E | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Jeena Sikho Lifecare Limited | 7.30 | 106.03 | 33.23 | 21.96 | 469.07 Cr |
| Sandu Pharmaceuticals Limited | 1.83 | 21.34 | 5.03 | 36.34 | 69.93 Cr |
Promoters & Holding Pattern
Promoters: Rohit Asawa, Divya Asawa, Chanda Asawa, Rama Raju Penmatsa
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 60,00,000 | 95.14% |
| Promoter Holding Post Issue | 60,00,000 | 68.13% |
Strengths & Risks
- Revenue grew 105% in the latest reported year.
- Solid profit margin — 17.1%.
- Strong return on equity — 64%.
- Low leverage — debt/equity of 0.31.
- Backed by anchor investors — Rs 8 crore committed pre-issue.
- Lists on the exchange's SME platform, where trading is usually thinner than on the main board — selling at your price can be harder.
Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.
Company Information
About Himalaya Nutravedics
Founded in 2022, Himalaya Nutravedics is an Ayurvedic and nutraceutical manufacturing firm involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
Company Contact Information
Plot No. 101/A, Phase-III Industrial Development Park Cherlapally, Hindustan Cables Ltd, Uppal Hyderabad Telangana
Objects of the Issue
| Purpose | Amount (Cr) |
|---|---|
| Funding Working Capital Requirements | 13.75 |
| Business Development and Digital Marketing Activities | 7.50 |
| General Corporate Purposes | - |
Resources & Documents
Anchor Investors
Himalaya Nutravedics IPO - Quick Take
Himalaya Nutravedics has set a price band of Rs 100–Rs 106 per share for an issue size of Rs 27 crore. The stock listed with a 11.32% gain versus its issue price on September 29, 2026.
The issue is promoted by Rohit Asawa, Divya Asawa, Chanda Asawa, Rama Raju Penmatsa with Nirbhay Capital Services Pvt.Ltd. acting as lead manager. Anchor investors have committed Rs 8 crore ahead of the public issue — about 28% of the total issue size. Anchor allocation was completed on September 21, 2026. Net proceeds will primarily be used towards funding Working Capital Requirements (Rs 14 crore) and business Development and Digital Marketing Activities (Rs 8 crore).
At the upper end of the price band, the issue is priced at a post-issue P/E of 12.63x. On fundamentals, the company is posting revenue growth of 105.3%, a profit margin of 17.1%, return on equity of 63.9% in its most recent reported period. Listed peers in this segment include Jeena Sikho Lifecare Limited (P/E 106.03x) and Sandu Pharmaceuticals Limited (P/E 21.34x) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Frequently Asked Questions
Himalaya Nutravedics IPO GMP — What It Means
GMP stops mattering once the shares trade — it only ever estimated the listing price. No grey market premium was recorded for Himalaya Nutravedics before it listed.
See the full Himalaya Nutravedics GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
Same sector or same stage as Himalaya Nutravedics
No comments yet. Be the first to share your opinion!